Skip to content

Diabetes Risk After Acute Coronary Syndrome on statins

To evaluate the incidence of new onset diabetes in acute coronary syndrome patients on statins and evaluate the dose related risk.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025932
Enrollment
250
Registered
2020-06-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I219- Acute myocardial infarction, unspecified

Interventions

Intervention1: Atorvastatin 80 mg for 6 months followed by atorvastatin 10 mg for 6 months: Atorvastatin 80 mg for 6 months followed by atorvastatin 10 mg for 6 months orally once a day night Control

Sponsors

Rohit Walia
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 - 65 years Acute Coronary Syndrome patients Non diabetic

Exclusion criteria

Exclusion criteria: Diabetes Already taking lipid lowering drugs or hypoglycaemic drugs Hypo or hyperthyroid disorders Advanced Malignancy Advanced Heart Failure Taking steroids Renal failure Any chronic infection Genetic Hypercholestrolemic disorders

Design outcomes

Primary

MeasureTime frame
1. Incidence of new onset diabetes at 6 months with maximum dose of statinTimepoint: 1. Incidence of new onset diabetes at 6 months with maximum dose of statin

Secondary

MeasureTime frame
Cardiovascular Events during follow up over 1 year and difference between intensive and low intensity phase.Timepoint: 1 year;Degree of change in FBG , PPBG , HbA1c after 6 months from maximum to minimum dose.Timepoint: at 1 year of study drug initiation;Degree of change in FBG , PPBG , HbA1c from baseline to 6 months on maximum dose of statin Timepoint: 6 months

Countries

India

Contacts

Public ContactRohit Walia

All India Institute of Medical Science Rishikesh

rwalia7731@yahoo.in8800492549

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026